125 related articles for article (PubMed ID: 813947)
1. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
Bandisode MS; Boshell BR
Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
[No Abstract] [Full Text] [Related]
2. [Mazindol in the treatment of obese diabetic patients].
Dolecek R; Reil P; Skarpová O; Závada M
Vnitr Lek; 1976 Aug; 22(8):798-804. PubMed ID: 788327
[No Abstract] [Full Text] [Related]
3. AN 448 Sandoz (Mazindol) in the treatment of obesity.
Wallace AG
Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
Riesco J; Troncoso G; Costamaillere L; Rodríguez J
Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
[No Abstract] [Full Text] [Related]
5. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
Slama G; Selmi A; Hautecouverture M; Tchobroutsky G
Diabete Metab; 1978 Sep; 4(3):193-9. PubMed ID: 361463
[TBL] [Abstract][Full Text] [Related]
6. [Mazindol in the treatment of obesity in diabetics (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1977 Sep; 116(39):1214-7. PubMed ID: 922789
[No Abstract] [Full Text] [Related]
7. [Clinical use of mazindol in the treatment of essential obesity].
Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
[No Abstract] [Full Text] [Related]
8. Letter: Drugs in obesity.
Jackson WP; Vinik AI
S Afr Med J; 1975 May; 49(20):803. PubMed ID: 1098170
[No Abstract] [Full Text] [Related]
9. Maziniol in the treatment of obesity.
Sedgwick JP
Practitioner; 1975 Mar; 214(1281):418-20. PubMed ID: 1096123
[No Abstract] [Full Text] [Related]
10. [Clinical trial with a nonamphetaminic anoretic].
Campagnoli M
Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
[TBL] [Abstract][Full Text] [Related]
11. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
Sanders M; Breidahl H
Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
[No Abstract] [Full Text] [Related]
13. [Comparison of the anorectic effect of mazindol and placebo in obesity].
Tatoń J; Czech A; Koliński P; Podwysocka G
Pol Tyg Lek; 1979 Dec; 34(50):1967-70. PubMed ID: 395517
[No Abstract] [Full Text] [Related]
14. Double-blind evaluation of mazindol in refractory obesity.
Smith RG; Innes JA; Munro JF
Br Med J; 1975 Aug; 3(5978):284. PubMed ID: 1097046
[No Abstract] [Full Text] [Related]
15. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity].
Husmann F
Med Welt; 1976 Oct; 27(40):1904-8. PubMed ID: 790077
[No Abstract] [Full Text] [Related]
16. [Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].
Bratusch-Marrain P; Dudczak R; Waldhäusl W
Wien Klin Wochenschr; 1979 Jun; 91(13):455-8. PubMed ID: 380178
[TBL] [Abstract][Full Text] [Related]
17. A double-blind trial of mazindol using a very low calorie formula diet.
Baird IM; Howard AN
Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631
[TBL] [Abstract][Full Text] [Related]
18. A multi-centre general practice trial of mazindol in the treatment of obesity.
Maclay WP; Wallace MG
Practitioner; 1977 Mar; 218(1305):431-4. PubMed ID: 322112
[No Abstract] [Full Text] [Related]
19. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
Gołebiowska M; Chlebna-Sokoł D; Mastalska A; Zwaigzne-Raczyńska J
Przegl Lek; 1981; 38(2):311-4. PubMed ID: 7017826
[No Abstract] [Full Text] [Related]
20. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
Defelice EA; Chaykin LB; Cohen A
Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
